Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Preparation of Highly Water Soluble Tacrolimus Derivatives: Poly(Ethylene Glycol) Esters as Potential Prod rugs

  • Chung, Yong-Seog (Department of Chemistry, Institute for Basic Science, Chungbuk National University) ;
  • Cho, Hoon (Department of Chemistry, Institute for Basic Science, Chungbuk National University)
  • Published : 2004.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

Tacrolimus (FK506), which is isolated from Streptomyces tsukubaensis, is a new potent immu-nosuppressant. Because of poor solubility in water, the conventional intravenous dosage forms of tacrolimus contain surfactants such as cremophor EL (BASF Wyandotte Co.) or hydroge-nated polyoxy 60 castor oil (HCO-60) which may cause adverse effects. This study relates to a polymer-tacrolimus conjugate, which can be dissolved in water, formed by chemically binding the sparingly soluble drug, tacrolimus, with the water soluble polymer, methoxypoly(ethylene glycol) (mPEG). Water soluble tacrolimus-mPEG conjugates have been synthesized and shown to be function in vitro as prodrugs. These conjugates are in the form of an ester wherein the 24-, 32- or 24,32-positions are esterified. The desired 24-, 32- or 24,32-esterified com-pounds were obtained by initially acylating of tacrolimus with iodoacetic acid at the 24-,32-, or 24,32-positions and then reacting the resulting acylated tacrolimus with a mPEG in the pres-ence of a base such as sodium bicarbonate. These conjugates were converted again into tac-rolimus by the action of enzymes in human liver homogenate, and the half-lives of the conjugates are approximately 10 min in the homogenate, indicating that the esterified tacroli-mus derivatives may be practically applicable as a prod rug for the immunosuppressant.

Keywords

References

  1. Besarab, A., Jarrell, B. E., Hirsch, S., Carabasi, R. A., Cressman, M. D., andGreen, P., Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, cremophor EL. Transplantation, 44, 195-201 (1987) https://doi.org/10.1097/00007890-198708000-00005
  2. Bowers, V. D., Locker, S., Ames, S., Jennings, W., and Corry, R. J., The hemodynamic effects of cremophor-EL. Transplant-ation., 51, 847-850 (1991) https://doi.org/10.1097/00007890-199104000-00021
  3. Ennis, M., Lorenz, W., and Gerland, W., Modulation of histamine release from rat peritoneal mast cells by non-cytotoxic concentrations of the detergents Cremophor EL (oxethylated castor oil) and Triton X100. A possible explanation for unexpected adverse drug reactions? Agents and Actions, 18, 235-238 (1986) https://doi.org/10.1007/BF01988029
  4. Ennis, M., Lorenz, W., Kapp, B., Luben, L., and Schmal, A., Comparison of the histamine-releasing activity of cremophor EL and some of its derivatives in two experimental models: The in vivo anesthetized dog and in vitro rat peritoneal mast cells. Agents and Actions., 16, 265-268 (1985) https://doi.org/10.1007/BF01983156
  5. Hane, K., Fujioka, M., Namiki, Y., Kitagawa, T., Kihara, N., Shimatani, K., and Yasuda, T., Physico-chemical properties of FK-506. Iyakuhin Kenkyu, 23, 33-43 (1992)
  6. Harris, J. M. and Chess, R. B., Effect of pegylation on pharmaceuticals. Nature Reviews, 2, 214-221 (2003) https://doi.org/10.1038/nrd1033
  7. Howrie, D. L., Ptachcinski, R. J., Griffith, B. P., Hardesty, R. J., Rosenthal, J. T., Burckart, G. J., and Venkataramanan, R., Anaphylactoid reactions associated with parenteral cyclosporine use: Possible role of cremophor EL. Drug Intell. Clin. Pharm., 19, 425-427 (1985)
  8. Kino, T., Hatanaka, H., Hashimoto, M., Nishiyama, M., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H., and Imanaka, N., Tacrolimus, a novel immunosuppressant isolated from nStreptomyces. I. Fermentation, isolation and physico-chemical and biological characteristics. J. Antibiot., 40, 1249-1255 (1987a) https://doi.org/10.7164/antibiotics.40.1249
  9. Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H., and Ochiai, T., Tacrolimus, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of tacrolimus in vitro. J. Antibiot., 40, 1256-1265 (1987b) https://doi.org/10.7164/antibiotics.40.1256
  10. Kopecek, J., and Duncan, R., Targetable Polymeric Prodrugs. J. Antibiot., 6, 315-327 (1987)
  11. Kopecek, J., The Potential of Water-Soluble Polymeric Carriers in Targeted and Site-Specific Drug Delivery. J. Controlled Release., 11, 279-290 (1990) https://doi.org/10.1016/0168-3659(90)90140-O
  12. Maeda, H., Seymour, L. W., and Miyamoto, Y., Conjugates of anticancer agents and polymers: advantages of macromole-cular therapeutics in vivo. Bioconjug. Chem., 3, 351-362 (1992) https://doi.org/10.1021/bc00017a001
  13. Maeda, H., SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Deliv. Rev., 6, 181-202 (1991) https://doi.org/10.1016/0169-409X(91)90040-J
  14. Matthew, A. E., Mejillano, M. R., Nath, J. P., Himes, R. H., and Stella, V. J., Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity. J. Med. Chem., 35, 145-157 (1992) https://doi.org/10.1021/jm00079a019
  15. Mongelli, N., Pesenti, E., Suarato, A., Biasoli, G., Polymer-Bound Paclitaxel Derivatives. U.S. Patent, 5,362,831, (1994)
  16. Ninomiya, H., Hanada, T., Nakazawa, M., Aoki, T., Shibuya, A., Nagasawa, T., and Abe, T., Immunological erythroblastopenia induced by HCO-60 as a solvent of enocitabine (BH-AC). Nippon Ketseki Gakkai Zasshi. Acta Haematol. Jpn., 50, 777-783 (1987)
  17. Noguchi, Y., Wun, J., Duncan, R., Strohalm, R., Ulbrich, K., Akaike, T., and Maeda, H., Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues. Jpn. J. Cancer Res., 89, 307-314 (1998) https://doi.org/10.1111/j.1349-7006.1998.tb00563.x
  18. Ohta, S., Iwane, S., Katsura, T., Shimada, M., and Hayashi, S., Leukocytosis induced by BH-AC administration. Allergic reaction to castor oil HCO-60. A case report. Rinsho ketsueki-Jpn. J. Clin. Hematol. 26, 555-559 (1985)
  19. Okabe, S., Drug eruption by solution trioxyethylene hydro-genated castor oil (HCO-60) in vitamin $K_{2}$ . Nippon Hifuka Gakkai Zasshi-Jpn. J. Dermatol., 91, 759-762 (1981)
  20. Oliyai, R. and Stella, V. J., Prodrugs of Peptides and Proteins for Improved Formulation and Delivery. Annu. Rev. Pharmacol. Toxicol., 32, 521-544 (1993'1)
  21. Roman, I. D., Monte, M. J., Esteller, A., and Jimenez, R., Cholestasis in the rat by means of intravenous administration of cyclosporine vehicle, cremophor EL. Transplantation., 48, 554-558 (1989) https://doi.org/10.1097/00007890-198910000-00003
  22. Seymour, L. W., Ulbrich, K., Strohalm, J., Kopecek, J., and Duncan, R., The Pharmacokinetics of Polymer-Bound Adriamycin. Biochem. Pharmacol., 39, 1125-1131 (1990) https://doi.org/10.1016/0006-2952(90)90293-T
  23. Sokol, P. P., Capodagli, L. C., Dixon, M., Holohan, P. D., Ross, C. R., Coulson, R., and Jones, D. P., Cyclosporin A and vehicle toxicity in primary cultures of rabbit renal proximal tubule cells. Am. J. Physiol., 259, C897-C903 (1990)